{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:42Z","timestamp":1787032902509,"version":"build-2736575974"},"reference-count":13,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2016]]},"DOI":"10.7883\/yoken.jjid.2014.577","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T18:05:17Z","timestamp":1438884317000},"page":"248-251","source":"Crossref","is-referenced-by-count":17,"title":["Nonsteroidal Anti-Inflammatory Drug and Aspirin Use, and Mortality among Critically Ill Pandemic H1N1 Influenza Patients: an Exploratory Analysis"],"prefix":"10.7883","volume":"69","author":[{"given":"Holly","family":"Epperly","sequence":"first","affiliation":[{"name":"Division of Epidemiology II, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances L.","family":"Vaughn","sequence":"additional","affiliation":[{"name":"U.S. Department of Health & Human Services (HHS), Office of the Assistant Secretary for Preparedness & Response (ASPR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Mosholder","sequence":"additional","affiliation":[{"name":"Division of Epidemiology II, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Maloney","sequence":"additional","affiliation":[{"name":"Division of Epidemiology II, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Rubinson","sequence":"additional","affiliation":[{"name":"U.S. Department of Health & Human Services (HHS), Office of the Assistant Secretary for Preparedness & Response (ASPR)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340:1377-82.","DOI":"10.1056\/NEJM199905063401801"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hama R. Rapid response to Hay AD, Redmond N, and Fletcher M. Antipyretic drugs for children. BMJ. 2006;333:4-5.","DOI":"10.1136\/bmj.333.7557.4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Eyers S, Weatherall M, Shirtcliffe P, et al. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med. 2010;103:403-11.","DOI":"10.1258\/jrsm.2010.090441"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Herxheimer A, Clarke M, Edwards R, et al. A\/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir. BMJ. 2009;339:b3048.","DOI":"10.1136\/bmj.b3048"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Simmons C, Farrar J. Insights into inflammation and influenza. N Engl J Med. 2008;359:1621-3.","DOI":"10.1056\/NEJMcibr0805865"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nagao T, Morishima T, Kimura H, et al. Prognostic factors in influenza-associated encephalopathy. Pediatr Infect Dis J. 2008;27:384-9.","DOI":"10.1097\/INF.0b013e318162a13b"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sugaya N. Influenza-associated encephalopathy in Japan. Semin Pediatr Infect Dis. 2002;13:79-84.","DOI":"10.1053\/spid.2002.122993"},{"key":"8","unstructured":"8. Available at <http:\/\/www.ardsnet.org\/>. Accessed February 27, 2013."},{"key":"9","unstructured":"9. Available at <http:\/\/www.palisi.org\/>. Accessed February 27, 2013."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40:1487-98.","DOI":"10.1097\/CCM.0b013e3182416f23"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009–2010 influenza pandemic in the United States. Pediatrics. 2011;128:e1450-8.","DOI":"10.1542\/peds.2011-0774"},{"key":"12","unstructured":"12. SAS Institute Inc. Base SAS 9.3 Procedures Guide. Cary, NC: 2011."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vandermeer ML, Thomas AR, Kamimoto L, et al. Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis. 2012;205:13-9.","DOI":"10.1093\/infdis\/jir695"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/3\/69_JJID.2014.577\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T23:52:22Z","timestamp":1567036342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/3\/69_JJID.2014.577\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2014.577","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}